Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.29)
# 3,458
Out of 4,863 analysts
337
Total ratings
34.55%
Success rate
-14.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $36.18 | -72.36% | 13 | Jun 16, 2025 | |
| TIL Instil Bio | Reiterates: Buy | $125 | $34.23 | +265.18% | 17 | Jun 5, 2025 | |
| AVTX Avalo Therapeutics | Assumes: Buy | $15 | $4.87 | +208.01% | 1 | Jun 2, 2025 | |
| BOLD Boundless Bio | Initiates: Buy | $5 | $1.05 | +376.19% | 1 | Jun 2, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $72 | $53.98 | +33.38% | 36 | May 29, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $30 | $8.31 | +261.01% | 3 | May 29, 2025 | |
| KYTX Kyverna Therapeutics | Upgrades: Buy | $4 → $5 | $3.23 | +54.80% | 7 | May 27, 2025 | |
| CTMX CytomX Therapeutics | Reiterates: Buy | $5 | $2.75 | +81.82% | 10 | May 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $65 | $41.36 | +57.16% | 3 | May 20, 2025 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $50 | $35.59 | +40.49% | 3 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $3.94 | +280.71% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $19.73 | +128.08% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $100 | $13.54 | +638.55% | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.14 | +345.86% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.97 | +52.28% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $36.83 | +103.64% | 37 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $20 | $9.91 | +101.92% | 12 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $6.16 | +305.84% | 6 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $10.42 | +283.88% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.32 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.43 | +389.51% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.20 | +150.00% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.58 | +247.58% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.53 | +1,613.31% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.42 | +187.91% | 19 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.16 | +143.51% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $19.78 | +122.45% | 13 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $12.58 | +257.71% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.45 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.38 | +44,202,798.55% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.48 | - | 4 | Jun 2, 2023 |
Sarepta Therapeutics
Jun 16, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $36.18
Upside: -72.36%
Instil Bio
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $34.23
Upside: +265.18%
Avalo Therapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $4.87
Upside: +208.01%
Boundless Bio
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.05
Upside: +376.19%
Halozyme Therapeutics
May 29, 2025
Reiterates: Buy
Price Target: $72
Current: $53.98
Upside: +33.38%
Intellia Therapeutics
May 29, 2025
Reiterates: Buy
Price Target: $30
Current: $8.31
Upside: +261.01%
Kyverna Therapeutics
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $3.23
Upside: +54.80%
CytomX Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.75
Upside: +81.82%
CRISPR Therapeutics AG
May 20, 2025
Reiterates: Buy
Price Target: $65
Current: $41.36
Upside: +57.16%
Ionis Pharmaceuticals
May 20, 2025
Reiterates: Buy
Price Target: $50
Current: $35.59
Upside: +40.49%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $3.94
Upside: +280.71%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $19.73
Upside: +128.08%
May 8, 2025
Maintains: Buy
Price Target: $115 → $100
Current: $13.54
Upside: +638.55%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $3.14
Upside: +345.86%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $1.97
Upside: +52.28%
Apr 16, 2025
Reiterates: Buy
Price Target: $75
Current: $36.83
Upside: +103.64%
Apr 16, 2025
Reiterates: Neutral
Price Target: $20
Current: $9.91
Upside: +101.92%
Apr 14, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $6.16
Upside: +305.84%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $10.42
Upside: +283.88%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.32
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.43
Upside: +389.51%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.20
Upside: +150.00%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.58
Upside: +247.58%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.53
Upside: +1,613.31%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $10.42
Upside: +187.91%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $6.16
Upside: +143.51%
Feb 25, 2025
Reiterates: Buy
Price Target: $44
Current: $19.78
Upside: +122.45%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $12.58
Upside: +257.71%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.45
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.38
Upside: +44,202,798.55%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.48
Upside: -